MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Total Assets Summary of MediPharm Labs Corp.

MediPharm Labs Corp.'s latest annual total assets in 2023 was 63.93 Million CAD , down -2.38% from previous year.
MediPharm Labs Corp.'s latest quarterly total assets in 2024 Q2 was 59.84 Million CAD , down -2.29% from previous quarter.
MediPharm Labs Corp. reported annual total assets of 65.49 Million CAD in 2022, down -29.09% from previous year.
MediPharm Labs Corp. reported annual total assets of 92.36 Million CAD in 2021, down -21.88% from previous year.
MediPharm Labs Corp. reported quarterly total assets of 59.84 Million CAD for 2024 Q2, down -2.29% from previous quarter.
MediPharm Labs Corp. reported quarterly total assets of 63.93 Million CAD for 2023 Q4, down -5.98% from previous quarter.

Annual Total Assets Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Total Assets of MediPharm Labs Corp. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	63.93 Million CAD	-2.38%
2022	65.49 Million CAD	-29.09%
2021	92.36 Million CAD	-21.88%
2020	118.23 Million CAD	-29.97%
2019	168.83 Million CAD	295.12%
2018	42.72 Million CAD	10582.25%
2017	400 Thousand CAD	52.56%
2016	262.18 Thousand CAD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	61.24 Million CAD	-4.21%
2024 Q2	59.84 Million CAD	-2.29%
2023 Q4	63.93 Million CAD	-5.98%
2023 FY	63.93 Million CAD	-2.38%
2023 Q2	73.52 Million CAD	18.49%
2023 Q1	62.05 Million CAD	-5.26%
2023 Q3	68 Million CAD	-7.5%
2022 Q2	79.24 Million CAD	-6.31%
2022 Q4	65.49 Million CAD	-8.06%
2022 FY	65.49 Million CAD	-29.09%
2022 Q1	84.58 Million CAD	-8.42%
2022 Q3	71.23 Million CAD	-10.1%
2021 Q1	137.32 Million CAD	16.15%
2021 FY	92.36 Million CAD	-21.88%
2021 Q4	92.36 Million CAD	-21.86%
2021 Q3	118.19 Million CAD	-7.79%
2021 Q2	128.18 Million CAD	-6.66%
2020 FY	118.23 Million CAD	-29.97%
2020 Q1	143.77 Million CAD	-14.84%
2020 Q2	178.76 Million CAD	24.34%
2020 Q3	150.22 Million CAD	-15.96%
2020 Q4	118.23 Million CAD	-21.3%
2019 Q2	174.31 Million CAD	148.54%
2019 FY	168.83 Million CAD	295.12%
2019 Q4	168.83 Million CAD	-7.76%
2019 Q3	183.02 Million CAD	4.99%
2019 Q1	70.13 Million CAD	64.15%
2018 Q3	461.02 Thousand CAD	-9.42%
2018 FY	42.72 Million CAD	10582.25%
2018 Q1	525.48 Thousand CAD	36.81%
2018 Q2	508.98 Thousand CAD	-3.14%
2018 Q4	42.72 Million CAD	9168.2%
2017 FY	400 Thousand CAD	52.56%
2017 Q4	384.1 Thousand CAD	-3.97%
2017 Q3	400 Thousand CAD	0.0%
2017 Q1	- CAD	0.0%
2016 FY	262.18 Thousand CAD	0.0%

Peer Total Assets Comparison of MediPharm Labs Corp.

Name	Total Assets	Total Assets Difference
Aurora Cannabis Inc.	838.67 Million CAD	92.376%
Avicanna Inc.	21.97 Million CAD	-191.005%
Avant Brands Inc.	82.55 Million CAD	22.549%
Cardiol Therapeutics Inc.	36.7 Million CAD	-74.213%
Crescita Therapeutics Inc.	24.59 Million CAD	-159.928%
Knight Therapeutics Inc.	945.49 Million CAD	93.238%
OrganiGram Holdings Inc.	298.45 Million CAD	78.577%
Canopy Growth Corporation	1.3 Billion CAD	95.083%
Willow Biosciences Inc.	6.67 Million CAD	-858.145%
Auxly Cannabis Group Inc.	261.9 Million CAD	75.588%